EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

EXO1 protects BRCA1-deficient cells against toxic DNA lesions

Bert van de Kooij, Anne Schreuder, Raphael Pavani, Veronica Garzero, Sidrit Uruci, Tiemen J Wendel, Arne van Hoeck, Marta San Martin Alonso, Marieke Everts, Dana Koerse, Elsa Callen, Jasper Boom und 7 weitere

Molecular Cell · 2024-02 · 84 (4) · 659-674.e7

DOI: 10.1016/j.molcel.2023.12.039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024-02. Verfasst von Bert van de Kooij und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Centre, Leiden 2333 ZC, the Netherlands; Department of Medical Oncology, University Medical C…. Hauptthemen laut MEDLINE: BRCA1 Protein, Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, Harvard University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inactivating mutations in the BRCA1 and BRCA2 genes impair DNA double-strand break (DSB) repair by homologous recombination (HR), leading to chromosomal instability and cancer. Importantly, BRCA1/2 deficiency also causes therapeutically targetable vulnerabilities. Here, we identify the dependency on the end resection factor EXO1 as a key vulnerability of BRCA1-deficient cells. EXO1 deficiency generates poly(ADP-ribose)-decorated DNA lesions during S phase that associate with unresolved DSBs and genomic instability in BRCA1-deficient but not in wild-type or BRCA2-deficient cells. Our data indicate that BRCA1/EXO1 double-deficient cells accumulate DSBs due to impaired repair by single-strand annealing (SSA) on top of their HR defect. In contrast, BRCA2-deficient cells retain SSA activity in the absence of EXO1 and hence tolerate EXO1 loss. Consistent with a dependency on EXO1-mediated SSA, we find that BRCA1-mutated tumors show elevated EXO1 expression and increased SSA-associated genomic scars compared with BRCA1-proficient tumors. Overall, our findings uncover EXO1 as a promising therapeutic target for BRCA1-deficient tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinNeoplasmsHumansBRCA2 ProteinDNA DamageDNA RepairDNA Repair EnzymesExodeoxyribonucleasesHomologous Recombination

Stichwörter der Autor:innen

BRCA1DNA double-strand break repairEXO1cancerhomologous recombinationsingle-strand annealingsynthetic lethality

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanDNA Repair EnzymesEXO1 protein, humanExodeoxyribonucleases

Autor:innen und Institutionen

  • Department of Human Genetics, Leiden University Medical Centre, Leiden 2333 ZC, the Netherlands; Department of Medical Oncology, University Medical Center Groningen, Groningen 9713 GZ, the Netherlands.
  • Department of Human Genetics, Leiden University Medical Centre, Leiden 2333 ZC, the Netherlands; Oncode Institute, Utrecht 3521 AL, the Netherlands.
  • Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Human Genetics, Leiden University Medical Centre, Leiden 2333 ZC, the Netherlands.
  • Oncode Institute, Utrecht 3521 AL, the Netherlands; Centre for Molecular Medicine, University Medical Centre Utrecht, Utrecht 3584 CG, the Netherlands.
  • Department of Medical Oncology, University Medical Center Groningen, Groningen 9713 GZ, the Netherlands.

Förderung

  • NCI NIH HHS
  • Intramural NIH HHS
  • Harvard University
  • Leids Universitair Medisch Centrum
  • National Institutes of Health
  • ERC
  • Oncode Institute
  • U.S. Department of Defense

Zitieren

APA

van de Kooij, B., Schreuder, A., Pavani, R., Garzero, V., Uruci, S., Wendel, T. J., van Hoeck, A., San Martin Alonso, M., Everts, M., Koerse, D., Callen, E., Boom, J., Mei, H., Cuppen, E., Luijsterburg, M. S., van Vugt, M. A. T. M., Nussenzweig, A., van Attikum, H., & Noordermeer, S. M. (2024). EXO1 protects BRCA1-deficient cells against toxic DNA lesions. Molecular Cell, 84(4), 659-674.e7. https://doi.org/10.1016/j.molcel.2023.12.039

Vancouver

van de Kooij B, Schreuder A, Pavani R, Garzero V, Uruci S, Wendel TJ, et al. EXO1 protects BRCA1-deficient cells against toxic DNA lesions. Molecular Cell. 2024;84(4):659-674.e7. doi:10.1016/j.molcel.2023.12.039

BibTeX
@article{vandeKooij2024,
  author = {van de Kooij, Bert and Schreuder, Anne and Pavani, Raphael and Garzero, Veronica and Uruci, Sidrit and Wendel, Tiemen J and van Hoeck, Arne and San Martin Alonso, Marta and Everts, Marieke and Koerse, Dana and Callen, Elsa and Boom, Jasper and Mei, Hailiang and Cuppen, Edwin and Luijsterburg, Martijn S and van Vugt, Marcel A T M and Nussenzweig, André and van Attikum, Haico and Noordermeer, Sylvie M},
  title = {EXO1 protects BRCA1-deficient cells against toxic DNA lesions},
  journal = {Molecular Cell},
  year = {2024},
  volume = {84},
  number = {4},
  pages = {659--674.e7},
  doi = {10.1016/j.molcel.2023.12.039}
}
Kostenlos starten →